Investor Announcements - 2015
|
| ||
PointMan™ shown to be a useful method for non-invasively determining plasma EGFR T790M mutation status in late stage lung cancer patients. | ||
| ||
Sonia Nicholas, SelectScience's Clinical Editor spoke to Dr Ricardo Del Sol, Senior Lecturer at the College of Medicine, Institute of Life Science at Swansea University, UK, about using PointMan™ DNA enrichment kits and how working with EKF Diagnostics is leading to new advances in cancer diagnostics. | ||
| ||
EKF Diagnostics announces that the Board of Directors have initiated a strategic review. | ||
| ||
| ||
| ||
| ||
Audited final results for the year ended 31 December 2014. | ||
| ||
EKF Diagnostics subsidiary , Selah Genomics, has announced a major, four-way collaboration with Greenville Health System (GHS, North Carolina), DecisionQ Corporation (Washington DC), and BD Technologies (New Jersey). | ||
| ||
Major 18 month collaboration in the US using PrecisionPath to provide genetic profiles of cancer tumours. | ||
| ||
EKF Diagnostics Holdings plc will announce its preliminary results. | ||
| |||||||||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.